DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
38 hedge funds and large institutions have $3.37M invested in DMK Pharmaceuticals Corporation Common Stock in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
67% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 18
Holders
38
Holding in Top 10
–
Calls
$238K
Puts
$8K
Top Buyers
| 1 | +$354K | |
| 2 | +$205K | |
| 3 | +$20K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$12.4K |
| 5 |
HR
Hayden Royal
Charlotte,
North Carolina
|
+$12.3K |
Top Sellers
| 1 | -$1.37M | |
| 2 | -$622K | |
| 3 | -$129K | |
| 4 |
Morgan Stanley
New York
|
-$69.2K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$61K |